Commenting on FDA Commissioner Gottlieb’s resignation, Catalyst President Nancy Bradish Myers says that “Gottlieb was pro-patient, pro-industry and pro-safety at the same time, which is difficult. He also used the office in a ‘forward-leaning way’ not seen often.”
“He kind of drove the conversation through very good communication externally. He was able to use a lot of the ideas percolating in the agency, package them and get them moved forward.”
Gottlieb also cultivated a good relationship not just with Trump and the White House, but also with lawmakers on Capitol Hill, “which gave him the credibility in those circles that he was going to do the right thing,” Ms. Myers says in the article.